Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 CAD | +2.37% | +5.49% | -48.36% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.36% | 19.41M | |
+24.45% | 47.02B | |
+49.67% | 41.86B | |
+0.38% | 41.76B | |
-4.27% | 28.8B | |
+12.59% | 26.05B | |
-21.26% | 19.15B | |
+3.98% | 12.55B | |
+31.54% | 12.34B | |
-4.44% | 11.82B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Says Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML; Adds Tuspetinib "Continues Broad Activity Across Mutations with Excellent Safety Profile"